NCT02816177

Brief Summary

Telemedicine-based care provides remote health and social care to maintain people's autonomy and increase their quality of life. The rapidly aging population has come with a significant increase in the prevalence of chronic diseases and their effects, and thus the need for increased care and welfare. This solutions give a new opportunity for diagnosis, treatment, education, and rehabilitation, and make it possible to monitor patients with a number of chronic diseases. It also reduces socioeconomic disparity with regard to access to care and gives equal chances to patients from urban and rural areas. This a randomized trial of telemedicine versus usual care alone to reduce hospitalization and emergency hospital admissions for Nursing Home Residents . After an initial assessment , each participant is monitored by teleconsultation on six occasions over 12 months. Patients with usual care have an initial and a 12 months assessments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
428

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 28, 2016

Completed
7 days until next milestone

Study Start

First participant enrolled

July 5, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 18, 2018

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

July 16, 2025

Status Verified

January 1, 2019

Enrollment Period

1.5 years

First QC Date

June 24, 2016

Last Update Submit

July 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy

    Proportion of patients who had an admission to the emergency or unscheduled hospitalization in health service or surgery

    12 month

Secondary Outcomes (1)

  • MAST

    12 months

Study Arms (2)

Telemedicine

EXPERIMENTAL

Usual care and telemedicine consultations during12 months.

Other: TelemedicineOther: Usual Care

Usual care alone

ACTIVE COMPARATOR

Usual care during12 months.

Other: Usual Care

Interventions

Telemedicine
TelemedicineUsual care alone

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elderly over 60 years
  • Resident in nursing homes
  • Resident with multiples chronic diseases with at least two comorbidities
  • Having given free and informed consent in writing and signed by himself and / or his legal representative

You may not qualify if:

  • Resident unaffiliated or not beneficiary of Social Security
  • Resident with a life-threatening disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Gériatrie

Limoges, France

Location

Related Publications (1)

  • Gayot C, Laubarie-Mouret C, Zarca K, Mimouni M, Cardinaud N, Luce S, Tovena I, Durand-Zaleski I, Laroche ML, Preux PM, Tchalla A. Effectiveness and cost-effectiveness of a telemedicine programme for preventing unplanned hospitalisations of older adults living in nursing homes: the GERONTACCESS cluster randomized clinical trial. BMC Geriatr. 2022 Dec 22;22(1):991. doi: 10.1186/s12877-022-03575-6.

MeSH Terms

Interventions

Telemedicine

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Thierry DANTOINE, MD

    CHU Limoges

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2016

First Posted

June 28, 2016

Study Start

July 5, 2016

Primary Completion

January 18, 2018

Study Completion

June 1, 2019

Last Updated

July 16, 2025

Record last verified: 2019-01

Locations